XT
FBRX

XTX Topco’s Forte Biosciences FBRX Stock Holding History

XTX Topco’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Buy
+29,947
New +$710K 0.01% 2229
2022
Q1 		– Sell
-1,083
Closed -$58K – 754
2021
Q4 		$58K Buy
+1,083
New +$72.8K 0.03% 549

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

XTX Topco's FBRX Position: Q2 2026 in Review

XTX Topco opened a new position in Forte Biosciences (FBRX) in Q2 2026: 29,947 shares worth $636K. The stake represents 0.01% of the portfolio and ranks #2229 among its holdings. This is a return to the name: XTX Topco previously reported a position in FBRX as recently as Q4 2021.

XTX Topco first reported a position in FBRX in Q4 2021 and has held it in 2 quarters since. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • XTX Topco held 29,947 shares of Forte Biosciences worth $636K as of Q2 2026.
  • Forte Biosciences was a new XTX Topco position in Q2 2026.
  • Forte Biosciences made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2229 holding.
  • XTX Topco first reported a position in Forte Biosciences in Q4 2021 and has held it in 2 quarters since.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.